Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

European Journal of Heart Failure, 2021

Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction

Woolley R., Ceelen D., Ouwerkerk W. et al.

Journal of Allergy and Clinical Immunology, 2021

Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis

Gülen T., Teufelberger A., Ekoff M. et al.

Scientific Reports, 2021

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study

Patel R., Lam C., Svedlund S. et al.

Journal of Cardiac Failure, 2021

Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF

Faxen U., Venkateshvaran A., Shah S. et al.

Nature Medicine, 2021

A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity

Zhou S., Butler-Laporte G., Nakanishi T. et al.

Acta Neurologica Scandinavica, 2021

Urokinase, CX3CL1, CCL2, TRAIL and IL‐18 induced by interferon‐β treatment

Zhukovsky C., Herman S., Wiberg A. et al.

Inflammatory Bowel Diseases, 2021

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease

Verstockt S., Verstockt B., Machiels K. et al.

Diabetes, 2021

Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes

Herder C., Maalmi H., Strassburger K. et al.

Cancers, 2021

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX

Stroes C., Schokker S., Molenaar R. et al.

Scientific Reports, 2021

The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients

Wu P., Lin Y., Chiu Y. et al.

BioEssays, 2021

Evaluation of 92 cardiovascular proteins in dried blood spots collected under field‐conditions

Broberg K., Svensson J., Grahn K. et al.

The Journal of Applied Laboratory Medicine, 2021

Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury—A Pilot Study

Chen M., Ren A., Prassas I. et al.

Biomarkers in Medicine, 2021

Associations of Serially Measured Pcsk9, Ldlr and Mpo with Clinical Outcomes in Heart Failure

Bouwens E., Schuurman A., Akkerhuis K. et al.

Computer Methods and Programs in Biomedicine, 2021

Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling

Yaşar ?., Çolak C., Yoloğlu S.

Frontiers in Bioengineering and Biotechnology, 2021

A LCMS Metabolomic Workflow to Investigate Metabolic Patterns in Human Intestinal Cells Exposed to Hydrolyzed Crab Waste Materials

Ó Fearghail F., Behan P., Engström N. et al.

Cardiovascular Ultrasound, 2021

Pre- and postoperative left atrial and ventricular volumetric and deformation analyses in severe aortic regurgitation

Jenner J., Ilami A., Petrini J. et al.

Cancer Research, 2021

Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer

Dagnino S., Bodinier B., Guida F. et al.

Scientific Reports, 2021

Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer

Jackson S., Van De Wyngard V., Pfeiffer R. et al.

Clinical Cancer Research, 2021

A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Monjazeb A., Giobbie-Hurder A., Lako A. et al.

Nature Medicine, 2021

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

Rozeman E., Hoefsmit E., Reijers I. et al.

4586 publications